Dangerous mistaken identity: Chaperone binds protein responsible for Alzheimer's disease

February 28, 2014, Technical University Munich
Dangerous mistaken identity
Although Hsp90 normally prefers prefolded proteins, it binds Tau proteins, which are responsible for Alzheimer's disease. An international team of scientists led by the Technische Universitaet Muenchen and the Helmholtz Zentrum Muenchen has unveiled the molecular recognition mechanisms that play a role here. This image shows the Hsp90-Tau protein complex (light blue: Hsp90, orange: tau-protein). Credit: Tobias Madl/Technische Universitaet Muenchen/Helmholtz Zentrum Muenchen

Proteins like the so-called heat shock protein Hsp90 play an important role in almost all processes within human cells. They help other proteins fold into their three-dimensional structure or return damaged proteins back into their proper shape.

Recently, there has been increasing evidence indicating that the HSP90 may also be involved in the folding processes of the . Deposits of tau proteins in brain cells are typical for Alzheimer's disease and are held responsible for decaying nerve cells.

However, while dissolved tau proteins look more like long, stretched chains, HSP90 binds predominantly proteins that have already been prefolded. This contradiction has now been resolved by an international team headed by Dr. Tobias Madl, leader of the BioSysNet Working Group and TUM Junior Fellow at the Technische Universität München and leader of the Emmy-Noether Group Structural Biology of Signal Transduction at the Institute of Structural Biology at the Helmholz Zentrum München, as well as Prof. Stefan Rüdiger from the Dutch University of Utrecht.

Detective work

Using a combination of very different techniques like magnetic resonance spectroscopy, small-angle X-ray scattering and computer modeling, they successfully determined structure and dynamics of the interactions between the two biomolecules: For Hsp90 the tau protein looks like a prefolded larger protein. Furthermore they were able to deduce how Hsp90 influences the aggregation of tau proteins with one another.

"Deposits of tau proteins can cause Alzheimer's disease. We have discovered the protein regions in which the proteins interact. This is a novel and important starting point for influencing structural formation and for developing future therapies for Alzheimer's disease," says Madl.

In addition to Alzheimer's disease, further neuro-degenerative diseases are caused by protein aggregation. Chaperones also play a role in the development of cancer and cystic fibrosis. These scientific insights thus provide an important basis for better understanding the disease mechanisms.

Explore further: Stress-related protein speeds progression of Alzheimer's disease

More information: Cell, 156, (5), 963-974 DOI: 10.1016/j.cell.2014.01.037

Related Stories

Stress-related protein speeds progression of Alzheimer's disease

September 4, 2013
A stress-related protein genetically linked to depression, anxiety and other psychiatric disorders contributes to the acceleration of Alzheimer's disease, a new study led by researchers at the University of South Florida ...

Brain cell activity regulates Alzheimer's protein

February 26, 2014
Increased brain cell activity boosts brain fluid levels of a protein linked to Alzheimer's disease, according to new research from scientists at Washington University School of Medicine in St. Louis.

Newly identified antibodies effectively treat Alzheimer's-like disease in mice

September 26, 2013
Alzheimer's disease is characterized by the accumulation of particular toxic proteins in the brain that are believed to underlie the cognitive decline in patients. A new study conducted in mice suggests that newly identified ...

New Alzheimer's research suggests possible cause: The interaction of proteins in the brain

June 19, 2013
For years, Alzheimer's researchers have focused on two proteins that accumulate in the brains of people with Alzheimer's and may contribute to the disease: plaques made up of the protein amyloid-beta, and tangles of another ...

Natural fungal products could offer potential Alzheimer's therapy

February 27, 2014
A team of researchers at the University of Kansas, including T. Chris Gamblin, associate professor of molecular biosciences, and Berl Oakley, Irving S. Johnson Distinguished Professor of Molecular Biology, has shown that ...

Recommended for you

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.